ATXN3 and Spinocerebellar ataxia type 3: In summary, we established efficient methods for one-step genetic correction in SCA3 iPSCs using CRISPR/Cas9 technology and subsequently developed SCA3 disease modeling in cerebellar region-specific and disease-specific differentiated neurons.